Allbee discusses Oregon Psilocybin Services' work over the last two years, and what to expect in the coming months as OPS implements Measure 109.
Plus: Barriers to vets seeking psychedelic-assisted therapy, and 2022 in review
Evans discusses the Challenging Psychedelic Experiences Project and what he and his co-researchers hope to learn from the data they collect.
Plus: Results from psychedelic brain imaging feasibility study and gaining clarity on perennial psychedelic research issues
Whiteman discusses how insects’ behavior may have given rise to plants and fungi with psychoactive properties.
Plus: Psilocybin and depression, Oregon, and Prince Harry
Pickard discusses his research, and how the psychedelics world has changed over his lifetime.
Plus: Quebec pays for psilocybin therapy, and Indigenous ethical principles to guide Western psychedelic research

December 2022

Mycoskie on his psychedelic philanthropy and investments, and what he hopes that accomplishes.
Plus: Boom and busts of shroom stores and Health Canada releases guidance on psychedelic trials
Priest discusses his organization Ligare and the role of religion in psychedelics.
Plus: DEA releases final 2023 drug quotas and Berkeley resolution could decriminalize psychedelics